Side-by-side comparison of AI visibility scores, market position, and capabilities
FY2024 Sales: $88.8B (+4.3%) | Net Profit: $14.1B (+5.6%) | EPS: $5.79 | Adjusted EPS: $9.98 | FY2025 Guidance: Operational Sales Growth 2.5-3.5%, Adj EPS $10.75-$10.95 (+8.7% midpoint)
Johnson & Johnson is one of the world's largest healthcare companies, founded in 1886 by brothers Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson in New Brunswick, New Jersey, where the company remains headquartered. Established to manufacture ready-to-use surgical dressings at a time when post-operative infection was a leading cause of surgical mortality, J&J was built on the scientific principles of antiseptic surgery advocated by Joseph Lister. The company trades on the NYSE under ticker JNJ and has evolved over 135+ years from a consumer health products manufacturer into a focused MedTech and pharmaceutical enterprise, completing the spinoff of its consumer health segment (Kenvue) in 2023.\n\nJohnson & Johnson now operates through two segments: Innovative Medicine and MedTech. Innovative Medicine encompasses oncology, immunology, neuroscience, infectious disease, and cardiovascular pharmaceutical products — including blockbusters Darzalex, Stelara, Tremfya, and Rybrevant. The MedTech segment includes surgical robotics (Ottava platform in development), electrophysiology (Abiomed, Biosense Webster), orthopedics (DePuy Synthes), and surgery systems, serving hospitals and surgical centers worldwide. Following the Kenvue separation, J&J is a pure-play healthcare technology and pharmaceutical company with significantly higher growth and margin profiles than its historical blended consumer-pharma-medtech structure.\n\nJohnson & Johnson reported FY2024 sales of $88.8 billion, up 4.3% year over year, with net profit of $14.1 billion, up 5.6%. The company's Innovative Medicine segment continues to grow driven by oncology and immunology portfolio strength, while MedTech benefits from procedure volume recovery and robotic surgery adoption. J&J's scale, R&D pipeline depth, and global commercial infrastructure — spanning more than 60 countries — position it as one of the two or three most consequential healthcare enterprises globally, with a patent portfolio, clinical trial network, and regulatory expertise that are nearly impossible to replicate.
Walmart Inc., $680.985B revenue FY2025, $15.51B net income (+32.8%), e-commerce: $120.9B (+20.8%), +27% globally, +22% US, 10,771 stores worldwide (4,606 US Walmart, 602 Sam's Club), 90% US population within 10 miles, 438M monthly online visitors, 6.
Walmart is the world's largest retailer and the largest company by revenue in the United States, founded by Sam Walton in Rogers, Arkansas in 1962. Built on the principle of everyday low prices (EDLP) and relentless supply chain efficiency, Walmart transformed American retail and became the defining model for mass-market discount retailing globally. Its scale — spanning 10,771 stores across 20 countries under banners including Walmart, Sam's Club, and Flipkart — gives it unmatched purchasing power and logistics infrastructure that competitors cannot easily replicate.\n\nWalmart's business spans brick-and-mortar supercenters, neighborhood market stores, wholesale clubs through Sam's Club, and a rapidly growing e-commerce operation. E-commerce revenue reached $120.9 billion in FY2025, a 20.8% year-over-year increase, cementing Walmart as the clear #2 US e-commerce player behind Amazon. Walmart+ membership, the company's subscription loyalty program offering free delivery, fuel discounts, and Paramount+ streaming, continues to grow and is central to deepening customer relationships and increasing purchase frequency beyond the physical store.\n\nWalmart reported $680.985 billion in revenue for FY2025 with $15.51 billion in net income, a 32.8% increase in profitability reflecting operating leverage and margin expansion. Its advertising business, Walmart Connect, is a high-margin revenue stream growing over 25% annually, establishing Walmart as a significant player in retail media networks alongside Amazon Advertising and Kroger. The combination of physical scale, e-commerce momentum, and advertising revenue diversification makes Walmart uniquely positioned to compete in the next era of retail.
Johnson & Johnson vs
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.